A Pilot Safety Study of Vaccination With Autologous, Lethally Irradiated Colorectal Cancer Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor
Phase of Trial: Phase I
Latest Information Update: 10 Jan 2018
Price : $35 *
At a glance
- Drugs Tumour cell vaccine-GVAX (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 04 Jan 2018 Status changed from suspended to recruiting.
- 17 Nov 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jul 2018.